Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] was reported 22332 times

Drugs of the Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 24 0.8000
1 PSEUDOANEURYSM INFECTION 41 0.7736
2 CYTOMEGALOVIRUS SYNDROME 84 0.5091
3 IMMUNE RECOVERY UVEITIS 27 0.4655
4 ENCEPHALITIS CYTOMEGALOVIRUS 203 0.4635
5 CYTOMEGALOVIRUS NEPHRITIS 22 0.4151
6 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 102 0.3423
7 SMOOTH MUSCLE CELL NEOPLASM 136 0.3254
8 PERICARDITIS FUNGAL 20 0.3030
9 VENA CAVA INJURY 25 0.2717
10 PERINEAL CYST 19 0.2603
11 PYELONEPHRITIS FUNGAL 19 0.2568
12 RETINITIS VIRAL 30 0.2479
13 HUMAN EHRLICHIOSIS 50 0.2392
14 CHORIOMENINGITIS LYMPHOCYTIC 16 0.2319
15 CYTOMEGALOVIRUS OESOPHAGITIS 85 0.2310
16 CYTOMEGALOVIRUS DUODENITIS 16 0.2286
17 CYTOMEGALOVIRUS VIRAEMIA 924 0.2075
18 CYTOMEGALOVIRUS GASTROENTERITIS 44 0.2037
19 CYTOMEGALOVIRUS ENTERITIS 71 0.1994
20 VASCULAR PSEUDOANEURYSM RUPTURED 46 0.1983
21 DELAYED GRAFT FUNCTION 134 0.1885
22 CYTOMEGALOVIRUS GASTRITIS 47 0.1858
23 DISSEMINATED CYTOMEGALOVIRAL INFECTION 39 0.1806
24 CEREBRAL NOCARDIOSIS 41 0.1760
25 CYTOMEGALOVIRUS CHORIORETINITIS 322 0.1650
26 CYTOMEGALOVIRUS INFECTION REACTIVATION 676 0.1529
27 CYTOMEGALOVIRUS COLITIS 345 0.1499
28 CUTANEOUS MUCORMYCOSIS 27 0.1467
29 CUTANEOUS NOCARDIOSIS 19 0.1462
30 NEW ONSET DIABETES AFTER TRANSPLANTATION 25 0.1445
31 INTRACRANIAL INFECTION 18 0.1440
32 RENAL CYST HAEMORRHAGE 32 0.1416
33 RETROPERITONEAL ABSCESS 17 0.1405
34 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 26 0.1390
35 CYTOMEGALOVIRUS INFECTION 2219 0.1334
36 CYTOMEGALOVIRUS HEPATITIS 47 0.1328
37 PNEUMONIA CYTOMEGALOVIRAL 253 0.1301
38 DEAFNESS CONGENITAL 26 0.1294
39 POLYOMAVIRUS VIRAEMIA 133 0.1252
40 EPSTEIN-BARR VIRAEMIA 138 0.1244
41 CONGENITAL CYTOMEGALOVIRUS INFECTION 21 0.1235
42 DRUG RESISTANCE MUTATION 21 0.1180
43 TRICHOPHYTOSIS 25 0.1179
44 PARVOVIRUS B19 INFECTION 105 0.1173
45 RENAL GRAFT INFECTION 27 0.1164
46 ADENOVIRAL HEPATITIS 27 0.1149
47 GASTROINTESTINAL MUCORMYCOSIS 19 0.1138
48 SCEDOSPORIUM INFECTION 79 0.1119
49 PERINEPHRIC COLLECTION 16 0.1119
50 ACANTHAMOEBA INFECTION 21 0.1117
51 LUNG TRANSPLANT REJECTION 72 0.1091
52 BK VIRUS INFECTION 362 0.1072
53 TERATOGENICITY 32 0.1060
54 PULMONARY NOCARDIOSIS 86 0.1044
55 VIRAL HAEMORRHAGIC CYSTITIS 74 0.1039
56 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 234 0.0998
57 HUMAN HERPESVIRUS 8 INFECTION 59 0.0969
58 CYTOMEGALOVIRUS TEST POSITIVE 171 0.0959
59 UREAPLASMA INFECTION 39 0.0956
60 CYTOMEGALOVIRUS ENTEROCOLITIS 72 0.0935
61 TRANSPLANT DYSFUNCTION 166 0.0929
62 CYTOMEGALOVIRUS ANTIGEN POSITIVE 17 0.0929
63 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 20 0.0905
64 PANCREAS TRANSPLANT REJECTION 18 0.0896
65 TOXOPLASMOSIS 96 0.0889
66 GRAFT LOSS 63 0.0869
67 NECROTISING RETINITIS 54 0.0844
68 ABDOMINAL WALL HAEMORRHAGE 22 0.0843
69 TRANSPLANT REJECTION 660 0.0823
70 COMPLICATIONS OF TRANSPLANTED LUNG 25 0.0814
71 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 409 0.0803
72 RENAL TRANSPLANT FAILURE 78 0.0789
73 DERMATOPHYTOSIS 22 0.0775
74 MONKEYPOX 21 0.0761
75 INFECTION REACTIVATION 87 0.0760
76 VASCULAR COMPRESSION 24 0.0759
77 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 23 0.0759
78 PULMONARY MUCORMYCOSIS 40 0.0758
79 ENTEROCOLITIS VIRAL 23 0.0757
80 COMPLICATIONS OF TRANSPLANTED KIDNEY 169 0.0744
81 PARVOVIRUS INFECTION 30 0.0743
82 MALACOPLAKIA 34 0.0742
83 HUMAN HERPESVIRUS 6 ENCEPHALITIS 21 0.0739
84 LYMPHOCELE 48 0.0723
85 EYE INFECTION FUNGAL 27 0.0698
86 MUCORMYCOSIS 181 0.0696
87 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 91 0.0691
88 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 16 0.0690
89 NOCARDIOSIS 176 0.0688
90 EPSTEIN-BARR VIRUS INFECTION 429 0.0686
91 DISSEMINATED ASPERGILLOSIS 32 0.0678
92 KIDNEY TRANSPLANT REJECTION 307 0.0639
93 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 86 0.0609
94 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 22 0.0606
95 EYE INFECTION TOXOPLASMAL 24 0.0605
96 HUMAN POLYOMAVIRUS INFECTION 32 0.0603
97 CYSTITIS HAEMORRHAGIC 242 0.0600
98 DISSEMINATED MUCORMYCOSIS 23 0.0584
99 PENILE ULCERATION 19 0.0581
100 OESOPHAGEAL ATRESIA 36 0.0576
101 IDIOPATHIC PNEUMONIA SYNDROME 17 0.0570
102 CITROBACTER INFECTION 24 0.0559
103 STRONGYLOIDIASIS 90 0.0557
104 GLOMERULOSCLEROSIS 35 0.0554
105 CYSTITIS VIRAL 21 0.0548
106 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 181 0.0547
107 FUNGAL ENDOCARDITIS 16 0.0532
108 ENTEROCOCCAL INFECTION 257 0.0531
109 INFECTION IN AN IMMUNOCOMPROMISED HOST 38 0.0529
110 ADENOVIRUS INFECTION 151 0.0520
111 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 15 0.0517
112 GRAFT VERSUS HOST DISEASE IN SKIN 114 0.0517
113 FUSARIUM INFECTION 36 0.0514
114 CEREBRAL TOXOPLASMOSIS 48 0.0514
115 MICROSPORIDIA INFECTION 18 0.0513
116 PATHOGEN RESISTANCE 450 0.0493
117 CEREBRAL ASPERGILLOSIS 30 0.0488
118 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 77 0.0480
119 ASPERGILLUS INFECTION 312 0.0475
120 PROTEUS INFECTION 34 0.0474
121 BLASTOMYCOSIS 23 0.0473
122 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 83 0.0469
123 RENAL ARTERY STENOSIS 64 0.0464
124 PNEUMOCYSTIS JIROVECII INFECTION 55 0.0460
125 KLEBSIELLA INFECTION 231 0.0456
126 VIRAEMIA 63 0.0455
127 ACINETOBACTER INFECTION 49 0.0447
128 TRICHODYSPLASIA SPINULOSA 17 0.0446
129 COMPLICATIONS OF TRANSPLANTED LIVER 16 0.0444
130 TRANSPLANT FAILURE 108 0.0440
131 TRANSPLANTATION COMPLICATION 18 0.0429
132 STENOTROPHOMONAS INFECTION 58 0.0427
133 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 15 0.0427
134 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 91 0.0427
135 INFECTIVE ANEURYSM 21 0.0424
136 CRYPTOCOCCOSIS 69 0.0423
137 HERPES SIMPLEX REACTIVATION 16 0.0420
138 CORONA VIRUS INFECTION 18 0.0419
139 ENTEROVIRUS INFECTION 36 0.0417
140 FUNGAL SEPSIS 34 0.0409
141 GRAFT VERSUS HOST DISEASE 292 0.0406
142 PERICARDITIS CONSTRICTIVE 17 0.0403
143 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 110 0.0398
144 CHRONIC ALLOGRAFT NEPHROPATHY 31 0.0396
145 BRAIN ABSCESS 100 0.0395
146 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 28 0.0389
147 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 287 0.0382
148 JC VIRUS INFECTION 61 0.0381
149 ACUTE GRAFT VERSUS HOST DISEASE 173 0.0378
150 GRAFT VERSUS HOST DISEASE IN LUNG 18 0.0377
151 RENAL TUBULAR ATROPHY 32 0.0363
152 DRUG RESISTANCE 927 0.0361
153 CERVICITIS 16 0.0359
154 ENCEPHALITIS VIRAL 43 0.0353
155 LIVER TRANSPLANT REJECTION 63 0.0350
156 ADRENAL MASS 29 0.0349
157 DISSEMINATED CRYPTOCOCCOSIS 26 0.0343
158 CRYPTOSPORIDIOSIS INFECTION 18 0.0343
159 PNEUMONIA NECROTISING 22 0.0340
160 PNEUMONIA PSEUDOMONAL 52 0.0339
161 THROMBOTIC MICROANGIOPATHY 329 0.0337
162 GASTROENTERITIS ESCHERICHIA COLI 18 0.0329
163 RETINAL ISCHAEMIA 20 0.0327
164 BRONCHOPULMONARY ASPERGILLOSIS 253 0.0326
165 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 39 0.0325
166 ENCEPHALITIS HERPES 16 0.0324
167 INCISION SITE PAIN 38 0.0323
168 VARICELLA ZOSTER VIRUS INFECTION 67 0.0323
169 HUMAN HERPESVIRUS 6 INFECTION 61 0.0322
170 RENAL TUBULAR INJURY 39 0.0321
171 CORYNEBACTERIUM INFECTION 17 0.0318
172 PNEUMOCYSTIS JIROVECII PNEUMONIA 316 0.0314
173 OPHTHALMIC HERPES SIMPLEX 18 0.0312
174 CAROTID ARTERIOSCLEROSIS 32 0.0310
175 NEPHROPATHY TOXIC 347 0.0309
176 KIDNEY FIBROSIS 53 0.0305
177 SUPERINFECTION BACTERIAL 24 0.0303
178 BACTERIURIA 17 0.0301
179 RED BLOOD CELLS URINE POSITIVE 29 0.0300
180 HEPATITIS VIRAL 24 0.0299
181 INTERVERTEBRAL DISC SPACE NARROWING 24 0.0298
182 ARTERIAL HAEMORRHAGE 34 0.0297
183 APLASIA PURE RED CELL 102 0.0296
184 COLON INJURY 17 0.0296
185 BRONCHOSTENOSIS 16 0.0293
186 ENTEROCOCCAL BACTERAEMIA 31 0.0292
187 HEART TRANSPLANT REJECTION 30 0.0289
188 TRACHEOBRONCHITIS 22 0.0286
189 PNEUMONIA CRYPTOCOCCAL 27 0.0286
190 CARDIAC INFECTION 21 0.0280
191 TERMINAL ILEITIS 17 0.0277
192 CHRONIC GRAFT VERSUS HOST DISEASE 100 0.0277
193 ASPERGILLOSIS 36 0.0275
194 RECTAL PROLAPSE 33 0.0273
195 INTUSSUSCEPTION 26 0.0272
196 BONE MARROW TOXICITY 32 0.0270
197 PSEUDOMONAL BACTERAEMIA 23 0.0269
198 OBLITERATIVE BRONCHIOLITIS 35 0.0267
199 KLEBSIELLA SEPSIS 30 0.0266
200 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 132 0.0265
201 STREPTOCOCCAL BACTERAEMIA 28 0.0257
202 IMMUNE RECONSTITUTION SYNDROME 33 0.0256
203 METAPNEUMOVIRUS INFECTION 20 0.0255
204 BACTERIAL SEPSIS 83 0.0255
205 AORTIC DILATATION 28 0.0252
206 GRAFT VERSUS HOST DISEASE IN LIVER 18 0.0251
207 PARAINFLUENZAE VIRUS INFECTION 38 0.0250
208 SYSTEMIC MYCOSIS 29 0.0248
209 CHORIORETINITIS 16 0.0248
210 PSEUDOMONAS INFECTION 212 0.0247
211 ACTINIC KERATOSIS 64 0.0246
212 ANAL ULCER 20 0.0245
213 MYCOBACTERIUM AVIUM COMPLEX INFECTION 65 0.0242
214 SEPTIC EMBOLUS 20 0.0240
215 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 22 0.0238
216 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 20 0.0237
217 RENAL VEIN THROMBOSIS 16 0.0237
218 BRAIN HERNIATION 70 0.0234
219 ANISOCYTOSIS 15 0.0228
220 HAEMOLYTIC URAEMIC SYNDROME 52 0.0224
221 SYSTEMIC CANDIDA 56 0.0223
222 ESCHERICHIA INFECTION 183 0.0222
223 MULTIPLE ORGAN DYSFUNCTION SYNDROME 626 0.0221
224 CAMPYLOBACTER INFECTION 18 0.0217
225 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 20 0.0216
226 PNEUMONIA FUNGAL 83 0.0210
227 MENINGITIS VIRAL 28 0.0204
228 FUNGAEMIA 32 0.0203
229 HEPATOSPLENOMEGALY 51 0.0199
230 ENTEROBACTER INFECTION 33 0.0196
231 LEUKOPENIA 976 0.0195
232 VENOOCCLUSIVE LIVER DISEASE 96 0.0194
233 BICYTOPENIA 38 0.0194
234 RETINAL VASCULITIS 23 0.0193
235 URINARY TRACT INFECTION ENTEROCOCCAL 18 0.0193
236 KLEBSIELLA BACTERAEMIA 18 0.0189
237 LYMPHOPENIA 267 0.0189
238 VIRAL LOAD INCREASED 73 0.0188
239 NEUROLOGICAL DECOMPENSATION 43 0.0186
240 RETINITIS 32 0.0185
241 MENINGITIS CRYPTOCOCCAL 32 0.0183
242 DIFFUSE ALVEOLAR DAMAGE 21 0.0183
243 PNEUMONIA PNEUMOCOCCAL 27 0.0182
244 HYPOGAMMAGLOBULINAEMIA 117 0.0178
245 NEPHROGENIC DIABETES INSIPIDUS 20 0.0173
246 SECONDARY IMMUNODEFICIENCY 21 0.0173
247 PANCYTOPENIA 960 0.0172
248 ESCHERICHIA BACTERAEMIA 40 0.0170
249 PNEUMONIA KLEBSIELLA 31 0.0168
250 ORCHITIS 18 0.0167
251 STEROID DIABETES 25 0.0167
252 CYTOPENIA 203 0.0166
253 ESCHERICHIA SEPSIS 48 0.0165
254 NEUTROPENIC COLITIS 34 0.0164
255 PNEUMONIA STREPTOCOCCAL 18 0.0164
256 RENAL TUBULAR NECROSIS 161 0.0164
257 VENOOCCLUSIVE DISEASE 41 0.0164
258 GENE MUTATION 32 0.0162
259 ILEAL ULCER 16 0.0158
260 INFECTIOUS PLEURAL EFFUSION 24 0.0158
261 RHINOVIRUS INFECTION 61 0.0157
262 CANDIDA INFECTION 264 0.0156
263 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 149 0.0156
264 PYELONEPHRITIS ACUTE 30 0.0153
265 DISSEMINATED TUBERCULOSIS 39 0.0152
266 STAPHYLOCOCCAL SEPSIS 75 0.0152
267 MULTIPLE-DRUG RESISTANCE 47 0.0151
268 LYMPHADENOPATHY MEDIASTINAL 29 0.0151
269 ORGANISING PNEUMONIA 75 0.0151
270 CLOSTRIDIUM DIFFICILE COLITIS 160 0.0151
271 SQUAMOUS CELL CARCINOMA OF SKIN 91 0.0151
272 OESOPHAGEAL CANDIDIASIS 60 0.0150
273 NORMOCHROMIC NORMOCYTIC ANAEMIA 45 0.0150
274 HYDRONEPHROSIS 111 0.0148
275 HYPERPARATHYROIDISM SECONDARY 37 0.0148
276 VIRAL MUTATION IDENTIFIED 54 0.0146
277 URINARY TRACT INFECTION BACTERIAL 37 0.0146
278 ACUTE LUNG INJURY 17 0.0143
279 LUNG ABSCESS 30 0.0143
280 ATYPICAL MYCOBACTERIAL INFECTION 20 0.0141
281 AORTIC ARTERIOSCLEROSIS 36 0.0140
282 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 37 0.0139
283 RENAL TUBULAR DISORDER 39 0.0138
284 STAPHYLOCOCCAL SKIN INFECTION 17 0.0138
285 HERPES SIMPLEX 89 0.0137
286 SEPTIC SHOCK 595 0.0137
287 HYPERURICAEMIA 56 0.0136
288 PNEUMONIA INFLUENZAL 16 0.0134
289 MYCOBACTERIAL INFECTION 23 0.0133
290 STAPHYLOCOCCAL BACTERAEMIA 58 0.0133
291 AGRANULOCYTOSIS 248 0.0133
292 HEPATIC INFECTION 17 0.0133
293 MEAN CELL VOLUME INCREASED 34 0.0132
294 CLOSTRIDIUM COLITIS 16 0.0132
295 ESCHERICHIA URINARY TRACT INFECTION 56 0.0132
296 HYPERPARATHYROIDISM 27 0.0131
297 BACTERAEMIA 155 0.0130
298 LARGE INTESTINAL ULCER 35 0.0129
299 PNEUMONIA BACTERIAL 117 0.0127
300 GLOMERULONEPHRITIS 31 0.0127
301 PNEUMONIA VIRAL 40 0.0125
302 PSEUDOMEMBRANOUS COLITIS 28 0.0125
303 BILE DUCT STENOSIS 15 0.0125
304 BONE MARROW FAILURE 254 0.0125
305 NOROVIRUS INFECTION 18 0.0125
306 HYPERLACTACIDAEMIA 33 0.0123
307 NOSOCOMIAL INFECTION 27 0.0122
308 NORMOCYTIC ANAEMIA 18 0.0122
309 HYPERAMMONAEMIA 61 0.0122
310 PNEUMOMEDIASTINUM 22 0.0122
311 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 100 0.0121
312 HYPOPROTEINAEMIA 23 0.0121
313 SHOCK HAEMORRHAGIC 98 0.0120
314 LEFT VENTRICULAR HYPERTROPHY 51 0.0119
315 APLASTIC ANAEMIA 62 0.0119
316 LEUKAEMIA RECURRENT 20 0.0118
317 ENCEPHALITIS 81 0.0117
318 LIVER ABSCESS 37 0.0114
319 LUNG TRANSPLANT 40 0.0113
320 HIRSUTISM 15 0.0113
321 LYMPHOPROLIFERATIVE DISORDER 33 0.0112
322 CD4 LYMPHOCYTES DECREASED 24 0.0112
323 HISTIOCYTOSIS HAEMATOPHAGIC 33 0.0111
324 ACUTE RESPIRATORY DISTRESS SYNDROME 196 0.0111
325 RENAL TRANSPLANT 40 0.0111
326 RENAL TUBULAR ACIDOSIS 24 0.0110
327 VASCULAR PSEUDOANEURYSM 19 0.0109
328 PNEUMOCYSTIS JIROVECI PNEUMONIA 24 0.0108
329 OLIGURIA 66 0.0106
330 FUNGAL SKIN INFECTION 42 0.0104
331 GASTROINTESTINAL ULCER 23 0.0104
332 IMMUNE THROMBOCYTOPENIA 46 0.0100
333 MYELOSUPPRESSION 361 0.0100
334 RETROPERITONEAL HAEMATOMA 22 0.0099
335 PYELONEPHRITIS 86 0.0099
336 END STAGE RENAL DISEASE 181 0.0099
337 OESOPHAGEAL ULCER 38 0.0099
338 GRANULOMA 34 0.0098
339 HEPATIC NECROSIS 37 0.0098
340 HAEMATOLOGICAL INFECTION 24 0.0098
341 NEUTROPENIA 1333 0.0098
342 OPPORTUNISTIC INFECTION 18 0.0097
343 GUILLAIN-BARRE SYNDROME 47 0.0097
344 CAPILLARY LEAK SYNDROME 20 0.0097
345 FIBRIN D DIMER INCREASED 34 0.0096
346 HEPATITIS E 15 0.0095
347 HISTOPLASMOSIS DISSEMINATED 15 0.0094
348 DEVICE RELATED SEPSIS 19 0.0094
349 VITREOUS HAEMORRHAGE 26 0.0094
350 HEPATITIS CHOLESTATIC 55 0.0091
351 RESPIRATORY FAILURE 662 0.0091
352 LIVER TRANSPLANT 33 0.0091
353 INFECTED SKIN ULCER 17 0.0090
354 HYPERCAPNIA 27 0.0090
355 ENTEROCOLITIS 51 0.0088
356 LUNG INFILTRATION 78 0.0088
357 PULMONARY TUBERCULOSIS 37 0.0087
358 ABDOMINAL INFECTION 22 0.0086
359 DISSEMINATED INTRAVASCULAR COAGULATION 121 0.0086
360 ODYNOPHAGIA 51 0.0085
361 ANAEMIA MACROCYTIC 18 0.0084
362 HAEMATOTOXICITY 79 0.0083
363 PULMONARY HAEMORRHAGE 65 0.0083
364 RENAL IMPAIRMENT 693 0.0082
365 DIVERTICULUM INTESTINAL 36 0.0082
366 DIFFUSE LARGE B-CELL LYMPHOMA 63 0.0082
367 WOUND COMPLICATION 28 0.0082
368 ABDOMINAL ABSCESS 36 0.0081
369 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 31 0.0081
370 PARESIS 18 0.0081
371 DRUG LEVEL INCREASED 132 0.0080
372 THROMBOCYTOSIS 29 0.0079
373 BENIGN PROSTATIC HYPERPLASIA 40 0.0077
374 HYPERVOLAEMIA 38 0.0077
375 PULMONARY ALVEOLAR HAEMORRHAGE 43 0.0077
376 COVID-19 PNEUMONIA 90 0.0076
377 ENDOCARDITIS 39 0.0076
378 LUNG OPACITY 20 0.0076
379 HAEMORRHAGE INTRACRANIAL 113 0.0075
380 HYDROCEPHALUS 41 0.0075
381 MULTI-ORGAN FAILURE 130 0.0075
382 SPINAL STENOSIS 31 0.0075
383 HAEMODYNAMIC INSTABILITY 57 0.0075
384 STUPOR 24 0.0075
385 BACTERIAL INFECTION 138 0.0074
386 THROMBOTIC THROMBOCYTOPENIC PURPURA 26 0.0074
387 HYPOPHOSPHATAEMIA 54 0.0073
388 RESPIRATORY TRACT INFECTION VIRAL 17 0.0073
389 RESPIRATORY DISTRESS 200 0.0072
390 INTRAVENTRICULAR HAEMORRHAGE 18 0.0072
391 ORAL CANDIDIASIS 95 0.0072
392 DRUG LEVEL ABOVE THERAPEUTIC 33 0.0072
393 CACHEXIA 37 0.0072
394 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 36 0.0071
395 TUBULOINTERSTITIAL NEPHRITIS 133 0.0071
396 PROTEIN URINE PRESENT 35 0.0070
397 ACUTE MYELOID LEUKAEMIA RECURRENT 15 0.0070
398 LEUKOENCEPHALOPATHY 26 0.0070
399 GENERALISED OEDEMA 86 0.0069
400 BRAIN OEDEMA 87 0.0069
401 GASTROINTESTINAL NECROSIS 20 0.0069
402 SERUM SICKNESS 19 0.0068
403 HYPOALBUMINAEMIA 53 0.0068
404 HAEMOLYTIC ANAEMIA 61 0.0068
405 CHOLESTATIC LIVER INJURY 15 0.0067
406 CYTOKINE RELEASE SYNDROME 135 0.0067
407 CHOLESTASIS 129 0.0067
408 MIXED LIVER INJURY 20 0.0066
409 THROMBOCYTOPENIA 743 0.0066
410 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 40 0.0066
411 HYPERBILIRUBINAEMIA 68 0.0066
412 WOUND DEHISCENCE 22 0.0065
413 SPLENOMEGALY 76 0.0065
414 RETINAL HAEMORRHAGE 46 0.0065
415 RETINAL DETACHMENT 59 0.0064
416 GASTROINTESTINAL STROMAL TUMOUR 17 0.0064
417 GASTRIC ULCER 121 0.0064
418 SEPSIS 706 0.0063
419 OESOPHAGEAL STENOSIS 18 0.0063
420 FUNGAL INFECTION 208 0.0062
421 B-CELL LYMPHOMA 21 0.0062
422 FIBROSIS 19 0.0062
423 FEBRILE NEUTROPENIA 407 0.0061
424 ASCITES 180 0.0061
425 IMMUNOSUPPRESSION 54 0.0061
426 FEBRILE BONE MARROW APLASIA 26 0.0061
427 AORTIC VALVE INCOMPETENCE 26 0.0061
428 BLOOD CREATININE INCREASED 397 0.0061
429 LUNG CONSOLIDATION 17 0.0061
430 ENCEPHALOPATHY 149 0.0061
431 GASTROINTESTINAL TOXICITY 29 0.0060
432 ACUTE RESPIRATORY FAILURE 116 0.0060
433 ATYPICAL PNEUMONIA 18 0.0060
434 LYMPHOCYTE COUNT DECREASED 106 0.0060
435 ACUTE KIDNEY INJURY 905 0.0059
436 HYPOMAGNESAEMIA 82 0.0059
437 MACULAR OEDEMA 33 0.0059
438 DUODENITIS 18 0.0059
439 AUTOIMMUNE HAEMOLYTIC ANAEMIA 20 0.0058
440 BRAIN DEATH 18 0.0058
441 MALNUTRITION 65 0.0058
442 ENTERITIS 37 0.0058
443 COLITIS 217 0.0057
444 ORGAN FAILURE 23 0.0057
445 PNEUMOTHORAX 90 0.0057
446 TOXIC EPIDERMAL NECROLYSIS 86 0.0057
447 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 58 0.0056
448 UROSEPSIS 52 0.0056
449 CLOSTRIDIAL INFECTION 19 0.0056
450 HYPERKALAEMIA 196 0.0056
451 ANURIA 48 0.0056
452 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 33 0.0056
453 STAPHYLOCOCCAL INFECTION 183 0.0055
454 SHOCK 127 0.0055
455 GASTRIC PERFORATION 15 0.0055
456 CANDIDIASIS 22 0.0055
457 HYPERTRANSAMINASAEMIA 38 0.0055
458 OTITIS MEDIA 18 0.0054
459 METABOLIC ACIDOSIS 174 0.0054
460 HYPERCALCAEMIA 67 0.0054
461 DIARRHOEA HAEMORRHAGIC 50 0.0053
462 ELECTROLYTE IMBALANCE 62 0.0053
463 HIV INFECTION 16 0.0053
464 LUNG INFECTION 82 0.0053
465 URINE OUTPUT DECREASED 46 0.0053
466 HYPERNATRAEMIA 26 0.0052
467 SUBCUTANEOUS ABSCESS 25 0.0052
468 BRONCHIECTASIS 35 0.0052
469 PORTAL HYPERTENSION 16 0.0052
470 LARGE INTESTINE PERFORATION 36 0.0052
471 ENDOPHTHALMITIS 31 0.0052
472 TOXIC ENCEPHALOPATHY 26 0.0051
473 SUSPECTED OFF LABEL USE 23 0.0051
474 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 277 0.0050
475 NEUTROPHIL COUNT INCREASED 51 0.0050
476 NEPHROGENIC ANAEMIA 23 0.0050
477 HYPERTRIGLYCERIDAEMIA 29 0.0049
478 C-REACTIVE PROTEIN INCREASED 178 0.0049
479 POSTOPERATIVE WOUND INFECTION 33 0.0049
480 HEPATOMEGALY 48 0.0049
481 MYOPATHY 42 0.0049
482 NEUROTOXICITY 85 0.0048
483 HEPATIC FAILURE 146 0.0048
484 BLOOD UREA INCREASED 80 0.0048
485 CEREBRAL HAEMATOMA 16 0.0048
486 HEPATOCELLULAR INJURY 67 0.0047
487 TACHYPNOEA 64 0.0047
488 PNEUMONITIS 128 0.0047
489 INTRACRANIAL PRESSURE INCREASED 26 0.0047
490 PRE-ECLAMPSIA 22 0.0046
491 SWELLING OF EYELID 29 0.0046
492 BASAL CELL CARCINOMA 72 0.0046
493 PLEURAL EFFUSION 279 0.0046
494 ACIDOSIS 35 0.0046
495 CARDIAC DYSFUNCTION 17 0.0046
496 NEUROLOGICAL SYMPTOM 26 0.0045
497 LARGE INTESTINE POLYP 31 0.0045
498 ACUTE HEPATIC FAILURE 61 0.0045
499 GASTROINTESTINAL INFECTION 40 0.0045
500 ABDOMINAL TENDERNESS 22 0.0044
501 VASCULAR DEVICE INFECTION 20 0.0044
502 TONSILLITIS 23 0.0044
503 HYPOXIA 155 0.0044
504 PLEURISY 26 0.0044
505 TUMOUR LYSIS SYNDROME 38 0.0043
506 GASTROENTERITIS 63 0.0043
507 MUCOSAL INFLAMMATION 113 0.0043
508 HEPATIC CYTOLYSIS 55 0.0043
509 NECROSIS 24 0.0043
510 CLOSTRIDIUM DIFFICILE INFECTION 94 0.0043
511 BLOOD CREATINE INCREASED 19 0.0043
512 RENAL CYST 34 0.0043
513 HAEMOLYSIS 33 0.0043
514 PROTEINURIA 81 0.0043
515 HEMIPARESIS 72 0.0042
516 HEPATITIS 108 0.0042
517 HERPES VIRUS INFECTION 24 0.0042
518 RASH MACULO-PAPULAR 92 0.0041
519 DRUG LEVEL DECREASED 42 0.0041
520 FOETAL GROWTH RESTRICTION 25 0.0041
521 HYPOVOLAEMIA 24 0.0041
522 AMYLASE INCREASED 15 0.0041
523 HAEMODIALYSIS 34 0.0040
524 ARTERIOSCLEROSIS 38 0.0040
525 CHOLANGITIS 25 0.0040
526 DEVICE RELATED INFECTION 62 0.0040
527 HEPATIC FUNCTION ABNORMAL 150 0.0040
528 HYPERLIPIDAEMIA 48 0.0040
529 SKIN PAPILLOMA 16 0.0040
530 SPINAL OSTEOARTHRITIS 35 0.0040
531 INTERSTITIAL LUNG DISEASE 192 0.0040
532 PULMONARY MASS 59 0.0040
533 HEPATIC LESION 17 0.0039
534 ATRIOVENTRICULAR BLOCK FIRST DEGREE 17 0.0039
535 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
536 OFF LABEL USE 3421 0.0039
537 ONYCHOMYCOSIS 17 0.0039
538 NEPHROPATHY 36 0.0039
539 PRODUCT USE IN UNAPPROVED INDICATION 954 0.0038
540 ANAEMIA 728 0.0038
541 LEUKOCYTOSIS 68 0.0038
542 DYSLIPIDAEMIA 19 0.0037
543 CENTRAL NERVOUS SYSTEM LESION 51 0.0037
544 BUNDLE BRANCH BLOCK RIGHT 17 0.0037
545 FAILURE TO THRIVE 19 0.0037
546 DRUG LEVEL BELOW THERAPEUTIC 20 0.0036
547 RALES 21 0.0036
548 ASPIRATION 39 0.0036
549 RENAL FAILURE 472 0.0036
550 HEPATOTOXICITY 79 0.0035
551 BLOOD ALBUMIN DECREASED 28 0.0035
552 MENTAL STATUS CHANGES 98 0.0035
553 FACIAL PARALYSIS 30 0.0035
554 NEUTROPENIC SEPSIS 25 0.0035
555 HYPONATRAEMIA 197 0.0035
556 APHTHOUS ULCER 27 0.0035
557 COAGULOPATHY 58 0.0035
558 UVEITIS 47 0.0035
559 AUTOIMMUNE HEPATITIS 24 0.0034
560 PYREXIA 1187 0.0034
561 CARDIOGENIC SHOCK 49 0.0034
562 ORAL DISORDER 25 0.0034
563 HAEMATURIA 116 0.0034
564 NEPHROTIC SYNDROME 23 0.0034
565 MYOCLONUS 40 0.0034
566 SUBARACHNOID HAEMORRHAGE 34 0.0033
567 RESPIRATORY SYNCYTIAL VIRUS INFECTION 29 0.0033
568 ABSCESS 53 0.0033
569 INTENTIONAL PRODUCT USE ISSUE 290 0.0033
570 CEREBRAL ISCHAEMIA 17 0.0033
571 POLYURIA 27 0.0033
572 MENINGITIS 22 0.0033
573 LEFT VENTRICULAR DYSFUNCTION 22 0.0033
574 SKIN NECROSIS 17 0.0033
575 THERAPY NON-RESPONDER 146 0.0032
576 INTESTINAL PERFORATION 36 0.0032
577 MOUTH ULCERATION 67 0.0032
578 HEPATITIS B 19 0.0031
579 LOW BIRTH WEIGHT BABY 25 0.0031
580 BLOOD POTASSIUM INCREASED 51 0.0031
581 MYOCARDITIS 36 0.0031
582 NEUTROPHIL COUNT DECREASED 128 0.0031
583 ADRENAL INSUFFICIENCY 38 0.0031
584 LYMPHOMA 48 0.0031
585 WOUND INFECTION 34 0.0031
586 RENAL FAILURE ACUTE 131 0.0031
587 GENERALISED TONIC-CLONIC SEIZURE 51 0.0031
588 BLOOD LACTIC ACID INCREASED 16 0.0030
589 ATAXIA 36 0.0030
590 PERICARDIAL EFFUSION 70 0.0030
591 GAMMA-GLUTAMYLTRANSFERASE INCREASED 67 0.0030
592 LYMPHADENOPATHY 107 0.0030
593 DRUG INTERACTION 478 0.0030
594 ATELECTASIS 29 0.0030
595 GRANULOCYTOPENIA 17 0.0030
596 ATRIOVENTRICULAR BLOCK 23 0.0030
597 HYPERGLYCAEMIA 108 0.0030
598 HYPOKALAEMIA 136 0.0029
599 TRANSAMINASES INCREASED 65 0.0029
600 STATUS EPILEPTICUS 33 0.0029
601 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 75 0.0029
602 PERIPHERAL SENSORY NEUROPATHY 17 0.0029
603 DRUG-INDUCED LIVER INJURY 90 0.0029
604 LEUKAEMIA 27 0.0029
605 LIVER FUNCTION TEST ABNORMAL 83 0.0029
606 PERITONITIS 59 0.0028
607 PAPULE 20 0.0028
608 FOREIGN BODY SENSATION IN EYES 18 0.0028
609 VITAMIN D DECREASED 24 0.0028
610 HAEMOGLOBIN DECREASED 287 0.0028
611 CEREBRAL HAEMORRHAGE 100 0.0028
612 BLOOD BILIRUBIN INCREASED 75 0.0028
613 PNEUMONIA ASPIRATION 69 0.0028
614 LIVE BIRTH 23 0.0027
615 BLOOD DISORDER 22 0.0027
616 EOSINOPHILIA 48 0.0027
617 HEPATITIS C 33 0.0027
618 GLOMERULAR FILTRATION RATE DECREASED 33 0.0027
619 SKIN LESION 73 0.0027
620 HEPATIC STEATOSIS 49 0.0026
621 VIRAL INFECTION 87 0.0026
622 LIVER INJURY 64 0.0026
623 LUNG DISORDER 127 0.0026
624 GASTRITIS 68 0.0026
625 ILEUS 32 0.0026
626 TREATMENT FAILURE 213 0.0026
627 MYOSITIS 23 0.0026
628 WHITE BLOOD CELL COUNT INCREASED 98 0.0026
629 DUODENAL ULCER 18 0.0025
630 PULMONARY HYPERTENSION 53 0.0025
631 INFUSION SITE SWELLING 16 0.0025
632 TERMINAL STATE 17 0.0025
633 ALTERED STATE OF CONSCIOUSNESS 55 0.0025
634 RESPIRATORY TRACT INFECTION 66 0.0025
635 DEPRESSED LEVEL OF CONSCIOUSNESS 99 0.0025
636 HEPATOCELLULAR CARCINOMA 19 0.0025
637 SKIN INFECTION 28 0.0025
638 FAECES SOFT 18 0.0025
639 PNEUMONIA 798 0.0025
640 DECUBITUS ULCER 20 0.0025
641 COLITIS ULCERATIVE 109 0.0024
642 PULMONARY OEDEMA 109 0.0024
643 URINARY TRACT INFECTION 411 0.0024
644 ORAL HERPES 47 0.0024
645 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
646 INFECTION 347 0.0024
647 PHOTOPHOBIA 45 0.0024
648 BLOOD PRESSURE FLUCTUATION 57 0.0024
649 OSTEOMYELITIS 43 0.0024
650 PLATELET COUNT DECREASED 251 0.0024
651 DISEASE RECURRENCE 112 0.0024
652 VISUAL FIELD DEFECT 17 0.0024
653 CARDIAC ARREST 194 0.0023
654 PRODUCT USE ISSUE 437 0.0023
655 HALLUCINATION, VISUAL 49 0.0023
656 HEPATITIS ACUTE 15 0.0023
657 WHITE BLOOD CELL COUNT DECREASED 249 0.0023
658 ALANINE AMINOTRANSFERASE INCREASED 141 0.0023
659 OESOPHAGITIS 25 0.0023
660 PULMONARY TOXICITY 16 0.0023
661 ACUTE MYELOID LEUKAEMIA 35 0.0022
662 METASTASIS 16 0.0022
663 VASCULITIS 26 0.0022
664 TOXICITY TO VARIOUS AGENTS 373 0.0022
665 DIABETES MELLITUS 168 0.0022
666 RESTLESS LEGS SYNDROME 40 0.0022
667 FLUID OVERLOAD 32 0.0022
668 SMALL INTESTINAL OBSTRUCTION 27 0.0022
669 HERPES ZOSTER 126 0.0022
670 HEMIPLEGIA 18 0.0022
671 HAEMORRHOIDS 42 0.0022
672 UPPER GASTROINTESTINAL HAEMORRHAGE 36 0.0021
673 TRICUSPID VALVE INCOMPETENCE 17 0.0021
674 DISEASE PROGRESSION 253 0.0021
675 THERAPY PARTIAL RESPONDER 33 0.0021
676 KIDNEY INFECTION 41 0.0021
677 PULMONARY FIBROSIS 40 0.0021
678 MYELODYSPLASTIC SYNDROME 30 0.0021
679 PANCREATITIS ACUTE 46 0.0020
680 GASTROINTESTINAL INFLAMMATION 16 0.0020
681 CARDIOMYOPATHY 30 0.0020
682 FLANK PAIN 19 0.0020
683 EYE PAIN 114 0.0020
684 BLINDNESS 82 0.0020
685 PREMATURE DELIVERY 32 0.0020
686 HYPOPHAGIA 51 0.0020
687 RED BLOOD CELL COUNT DECREASED 57 0.0020
688 PREMATURE BABY 60 0.0020
689 CONDITION AGGRAVATED 605 0.0020
690 DRUG ERUPTION 35 0.0020
691 PRESYNCOPE 48 0.0020
692 CHRONIC KIDNEY DISEASE 150 0.0020
693 LIVER DISORDER 87 0.0020
694 HAEMATEMESIS 49 0.0019
695 CHOLECYSTITIS 23 0.0019
696 CIRCULATORY COLLAPSE 32 0.0019
697 GASTROINTESTINAL HAEMORRHAGE 156 0.0019
698 UPPER RESPIRATORY TRACT INFECTION 86 0.0019
699 BLOOD MAGNESIUM DECREASED 16 0.0019
700 PERICARDITIS 31 0.0018
701 DRUG INEFFECTIVE 2427 0.0018
702 SINUS TACHYCARDIA 26 0.0018
703 HAEMOPTYSIS 51 0.0018
704 RENAL DISORDER 85 0.0018
705 ULCER 29 0.0018
706 HEPATIC ENCEPHALOPATHY 17 0.0018
707 SKIN ULCER 47 0.0018
708 FOLLICULITIS 19 0.0018
709 ATRIAL FIBRILLATION 176 0.0018
710 PERITONITIS BACTERIAL 18 0.0018
711 FISTULA 20 0.0018
712 HYPOTENSION 356 0.0018
713 DIALYSIS 25 0.0018
714 OEDEMA 95 0.0017
715 JAUNDICE 47 0.0017
716 IMMUNODEFICIENCY 26 0.0017
717 COVID-19 306 0.0017
718 AUTOIMMUNE DISORDER 17 0.0017
719 CONJUNCTIVITIS 32 0.0017
720 DYSURIA 63 0.0017
721 DELIRIUM 59 0.0017
722 HAEMATOMA 44 0.0017
723 ASPARTATE AMINOTRANSFERASE INCREASED 90 0.0017
724 HYPOCALCAEMIA 32 0.0017
725 BLOOD IRON DECREASED 20 0.0017
726 EYELID PTOSIS 17 0.0017
727 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
728 RESPIRATORY DISORDER 49 0.0016
729 PETECHIAE 17 0.0016
730 ABDOMINAL PAIN 377 0.0016
731 POST PROCEDURAL COMPLICATION 31 0.0016
732 GASTROINTESTINAL DISORDER 144 0.0016
733 TACHYCARDIA 140 0.0016
734 DIARRHOEA 1014 0.0016
735 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
736 OEDEMA PERIPHERAL 191 0.0016
737 BRADYCARDIA 83 0.0016
738 SCHIZOPHRENIA 19 0.0016
739 APHASIA 47 0.0016
740 THROMBOSIS 125 0.0016
741 REBOUND EFFECT 17 0.0015
742 MELAENA 33 0.0015
743 PANCREATITIS 79 0.0015
744 BLINDNESS UNILATERAL 21 0.0015
745 NEOPLASM 17 0.0015
746 COMA 70 0.0015
747 RHABDOMYOLYSIS 61 0.0015
748 IMPAIRED HEALING 48 0.0015
749 DIABETIC KETOACIDOSIS 35 0.0015
750 CARDIAC FAILURE 116 0.0014
751 STEVENS-JOHNSON SYNDROME 32 0.0014
752 HEPATIC CIRRHOSIS 27 0.0014
753 INFLAMMATION 74 0.0014
754 OCULAR DISCOMFORT 16 0.0014
755 POLYNEUROPATHY 17 0.0014
756 MITRAL VALVE INCOMPETENCE 16 0.0014
757 SUBDURAL HAEMATOMA 20 0.0014
758 PRODUCTIVE COUGH 66 0.0014
759 CARDIO-RESPIRATORY ARREST 57 0.0014
760 CEREBRAL INFARCTION 33 0.0013
761 GLYCOSYLATED HAEMOGLOBIN INCREASED 34 0.0013
762 EPILEPSY 41 0.0013
763 OXYGEN SATURATION DECREASED 75 0.0013
764 TREATMENT NONCOMPLIANCE 73 0.0013
765 IMPAIRED GASTRIC EMPTYING 18 0.0013
766 CELLULITIS 65 0.0013
767 URINARY RETENTION 43 0.0013
768 ACUTE MYOCARDIAL INFARCTION 38 0.0013
769 HYPERTENSION 270 0.0013
770 FOETAL EXPOSURE DURING PREGNANCY 103 0.0013
771 HAEMATOCHEZIA 69 0.0012
772 MYDRIASIS 16 0.0012
773 FULL BLOOD COUNT DECREASED 25 0.0012
774 PRESCRIBED OVERDOSE 24 0.0012
775 LACTIC ACIDOSIS 40 0.0012
776 HEPATIC ENZYME INCREASED 84 0.0012
777 CYSTITIS 39 0.0012
778 CARDIOMEGALY 15 0.0012
779 DEEP VEIN THROMBOSIS 79 0.0012
780 CONFUSIONAL STATE 196 0.0012
781 VENTRICULAR TACHYCARDIA 20 0.0012
782 GENERAL PHYSICAL HEALTH DETERIORATION 139 0.0012
783 PULMONARY EMBOLISM 114 0.0012
784 SEROTONIN SYNDROME 23 0.0012
785 DYSPNOEA EXERTIONAL 45 0.0012
786 RENAL INJURY 35 0.0012
787 BODY TEMPERATURE INCREASED 24 0.0012
788 STOMATITIS 71 0.0012
789 DISORIENTATION 46 0.0012
790 HAEMATOCRIT DECREASED 23 0.0012
791 OSTEONECROSIS 38 0.0012
792 PROCEDURAL PAIN 32 0.0012
793 NERVOUS SYSTEM DISORDER 35 0.0011
794 DIPLOPIA 29 0.0011
795 VISUAL ACUITY REDUCED 37 0.0011
796 RASH ERYTHEMATOUS 53 0.0011
797 TREMOR 184 0.0011
798 DRUG TOXICITY 15 0.0011
799 EJECTION FRACTION DECREASED 17 0.0011
800 DECREASED APPETITE 248 0.0011
801 DEHYDRATION 142 0.0011
802 WEIGHT DECREASED 297 0.0011
803 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31 0.0011
804 MUSCULOSKELETAL DISCOMFORT 18 0.0010
805 FEAR 28 0.0010
806 COUGH 290 0.0010
807 EYE IRRITATION 59 0.0010
808 LIVER FUNCTION TEST INCREASED 22 0.0010
809 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
810 OCULAR HYPERAEMIA 48 0.0010
811 GASTROENTERITIS VIRAL 18 0.0010
812 PALLOR 27 0.0010
813 LOWER RESPIRATORY TRACT INFECTION 45 0.0010
814 BLOOD COUNT ABNORMAL 15 0.0010
815 ORTHOSTATIC HYPOTENSION 17 0.0010
816 PHOTOSENSITIVITY REACTION 16 0.0010
817 UNRESPONSIVE TO STIMULI 25 0.0010
818 SEIZURE 111 0.0010
819 LACRIMATION INCREASED 29 0.0010
820 PRESCRIBED UNDERDOSE 19 0.0010
821 DYSPHAGIA 89 0.0009
822 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
823 ABDOMINAL PAIN LOWER 23 0.0009
824 CHILLS 106 0.0009
825 BLOOD PRESSURE DECREASED 60 0.0009
826 ACCIDENTAL OVERDOSE 33 0.0009
827 CONVULSION 51 0.0009
828 HAEMORRHAGE 93 0.0009
829 CHROMATURIA 20 0.0009
830 VOMITING 416 0.0009
831 GLAUCOMA 17 0.0009
832 SKIN CANCER 19 0.0009
833 OSTEOPOROSIS 36 0.0009
834 VERTIGO 53 0.0009
835 DRUG INTOLERANCE 84 0.0009
836 NEURALGIA 21 0.0009
837 NEUROPATHY PERIPHERAL 82 0.0009
838 RECTAL HAEMORRHAGE 37 0.0009
839 ORAL PAIN 19 0.0008
840 FLUID RETENTION 43 0.0008
841 ARRHYTHMIA 40 0.0008
842 DEAFNESS 22 0.0008
843 SKIN DISORDER 28 0.0008
844 VISUAL IMPAIRMENT 104 0.0008
845 TASTE DISORDER 17 0.0008
846 EXPOSURE DURING PREGNANCY 52 0.0008
847 GOUT 15 0.0008
848 LETHARGY 48 0.0008
849 RESTLESSNESS 30 0.0008
850 RASH PAPULAR 18 0.0008
851 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 57 0.0008
852 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
853 INFLUENZA 89 0.0008
854 CHOLELITHIASIS 26 0.0008
855 BLOOD URINE PRESENT 15 0.0008
856 NO ADVERSE EVENT 143 0.0008
857 ABDOMINAL DISTENSION 82 0.0008
858 FAECES DISCOLOURED 17 0.0008
859 SWELLING FACE 51 0.0008
860 GASTROOESOPHAGEAL REFLUX DISEASE 63 0.0008
861 PRODUCT PRESCRIBING ISSUE 17 0.0008
862 MATERNAL EXPOSURE DURING PREGNANCY 69 0.0008
863 RHINORRHOEA 50 0.0008
864 EYE SWELLING 28 0.0008
865 COGNITIVE DISORDER 35 0.0007
866 AGITATION 55 0.0007
867 ASTHENIA 273 0.0007
868 ANHEDONIA 19 0.0007
869 NEOPLASM PROGRESSION 25 0.0007
870 MENTAL DISORDER 31 0.0007
871 EPISTAXIS 53 0.0007
872 VISION BLURRED 97 0.0007
873 BRONCHITIS 52 0.0007
874 BLOOD POTASSIUM DECREASED 21 0.0007
875 PLASMA CELL MYELOMA 27 0.0007
876 TYPE 2 DIABETES MELLITUS 23 0.0007
877 PSYCHOTIC DISORDER 20 0.0007
878 MYALGIA 115 0.0007
879 PRODUCT PRESCRIBING ERROR 16 0.0007
880 DYSPNOEA 377 0.0007
881 HALLUCINATION 50 0.0007
882 OVERDOSE 141 0.0007
883 NIGHT SWEATS 21 0.0007
884 RASH PRURITIC 35 0.0006
885 SWELLING 60 0.0006
886 HYPOGLYCAEMIA 31 0.0006
887 SINUSITIS 64 0.0006
888 INFUSION RELATED REACTION 41 0.0006
889 DYSKINESIA 25 0.0006
890 LABORATORY TEST ABNORMAL 18 0.0006
891 EXTRAPYRAMIDAL DISORDER 15 0.0006
892 THERAPY CESSATION 31 0.0006
893 NAUSEA 477 0.0006
894 RASH 258 0.0006
895 UNDERDOSE 43 0.0006
896 CHEST DISCOMFORT 60 0.0006
897 INTESTINAL OBSTRUCTION 22 0.0006
898 OROPHARYNGEAL PAIN 54 0.0006
899 BLOOD CHOLESTEROL INCREASED 27 0.0006
900 MALIGNANT NEOPLASM PROGRESSION 59 0.0006
901 RASH MACULAR 20 0.0006
902 ERYTHEMA 117 0.0006
903 ANGINA PECTORIS 16 0.0006
904 AMNESIA 35 0.0005
905 DYSARTHRIA 20 0.0005
906 DEATH 456 0.0005
907 THERAPEUTIC RESPONSE DECREASED 32 0.0005
908 CONSTIPATION 115 0.0005
909 TINNITUS 24 0.0005
910 CATARACT 31 0.0005
911 HYPOACUSIS 22 0.0005
912 BONE DENSITY DECREASED 16 0.0005
913 CHEST PAIN 93 0.0005
914 MUSCULAR WEAKNESS 57 0.0005
915 SKIN EXFOLIATION 42 0.0005
916 LOSS OF CONSCIOUSNESS 63 0.0005
917 HEART RATE INCREASED 48 0.0005
918 GASTRIC DISORDER 16 0.0005
919 MUSCULOSKELETAL PAIN 24 0.0005
920 ABDOMINAL DISCOMFORT 76 0.0005
921 HEADACHE 284 0.0005
922 BLISTER 25 0.0004
923 CEREBROVASCULAR ACCIDENT 75 0.0004
924 DISCOMFORT 27 0.0004
925 MALAISE 192 0.0004
926 INFLUENZA LIKE ILLNESS 36 0.0004
927 NEPHROLITHIASIS 20 0.0004
928 ANGIOEDEMA 19 0.0004
929 ILLNESS 43 0.0004
930 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
931 ANAPHYLACTIC REACTION 23 0.0004
932 DYSPHONIA 24 0.0004
933 MUSCULOSKELETAL STIFFNESS 34 0.0004
934 HOSPITALISATION 59 0.0004
935 DRY EYE 19 0.0004
936 SLEEP DISORDER 26 0.0004
937 DYSGEUSIA 27 0.0004
938 NASOPHARYNGITIS 66 0.0004
939 WEIGHT INCREASED 80 0.0004
940 FATIGUE 276 0.0004
941 HYPOAESTHESIA 53 0.0004
942 BLOOD PRESSURE INCREASED 54 0.0004
943 PERIPHERAL SWELLING 53 0.0003
944 INCORRECT DOSE ADMINISTERED 78 0.0003
945 INSOMNIA 91 0.0003
946 BONE PAIN 20 0.0003
947 JOINT SWELLING 40 0.0003
948 ABDOMINAL PAIN UPPER 68 0.0003
949 SOMNOLENCE 66 0.0003
950 MEDICATION ERROR 18 0.0003
951 CARDIAC FAILURE CONGESTIVE 26 0.0003
952 NASAL CONGESTION 19 0.0003
953 DIZZINESS 160 0.0003
954 INTENTIONAL PRODUCT MISUSE 28 0.0003
955 SYNCOPE 32 0.0003
956 BLOOD GLUCOSE INCREASED 60 0.0003
957 DYSPEPSIA 31 0.0003
958 EMOTIONAL DISTRESS 38 0.0003
959 BACK PAIN 72 0.0003
960 PRURITUS 118 0.0003
961 DEPRESSION 68 0.0003
962 PAIN 178 0.0003
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
964 FALL 91 0.0003
965 PALPITATIONS 32 0.0003
966 PAIN IN EXTREMITY 80 0.0003
967 NEOPLASM MALIGNANT 18 0.0003
968 ANXIETY 76 0.0003
969 PARAESTHESIA 42 0.0003
970 BALANCE DISORDER 23 0.0003
971 ILL-DEFINED DISORDER 16 0.0003
972 HYPERSENSITIVITY 48 0.0003
973 THERAPY INTERRUPTED 18 0.0003
974 GAIT DISTURBANCE 48 0.0003
975 UNEVALUABLE EVENT 18 0.0002
976 ALOPECIA 46 0.0002
977 ADVERSE EVENT 21 0.0002
978 INJURY 16 0.0002
979 MEMORY IMPAIRMENT 31 0.0002
980 CONTUSION 21 0.0002
981 HYPERHIDROSIS 28 0.0002
982 CARDIAC DISORDER 20 0.0002
983 ARTHRALGIA 85 0.0002
984 DRY SKIN 27 0.0002
985 URTICARIA 32 0.0002
986 PRODUCT DOSE OMISSION ISSUE 55 0.0002
987 SUICIDAL IDEATION 17 0.0002
988 MYOCARDIAL INFARCTION 31 0.0002
989 MUSCLE SPASMS 27 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
991 DRUG DOSE OMISSION 19 0.0001
992 FEELING ABNORMAL 15 0.0001